European Research Organisation on Genital Infection and Neoplasia (EUROGIN) Congress 2017

European Research Organisation on Genital Infection and Neoplasia Congress is organized by European Research Organisation on genital infection and neoplasia (EUROGIN) and would be held during Oct 08 - 11, 2017 at Amsterdam RAI Exhibition and Convention Centre, Amsterdam, Noord Holland, Netherlands.

The target audience for this medical event basically for Gynecologists, Oto-rhino-laryngologists / head & neck specialists, Proctologists and gastro-enterologists, GPs, Cytopathologists – Biologists, Students, residents and young researchers, Basic scientists - Epidemiologists. This cme conference has been approved with maximum of 21 hours of European external CME credits.

As one of the most important conferences on human papillomavirus infection and related cancers, our event continues to foster multidisciplinary interactions that are vital to making critical discoveries. The high-ranking scientific committee includes members representing a wide range of interests and scientific expertise that are required to develop an outstanding meeting. The program also encompasses state-of-the art science on ano-genital and head & neck cancer, inspires collaboration, and provides forums to share expertise and learn from the leading experts in these fields.

Program Objectives:

The EUROGIN congress offers a top-quality and innovative scientific program addressing highly relevant topics. One of the main strenghts of the meeting consists of the fact that it gathers outstanding international representatives from the academic sector, professional and patient organizations around the same table. The event's main objective consists of accelerating the translation of scientific dicoveries into day-to-day practice. Other objectives of the scientific program (training courses, plenary sessions, scientific sessions) are:

• Review the burden and epidemiology of HPV associated diseases in lower genital tract, anus and head & neck.
• Understanding the role of molecular testing in primary screening and prevention and their application in routine practice
• A review of recent developments in HPV infection, cancer prevention and control, including vulvar, anal and head & neck HPV induced diseses.
• Integrate the use of HPV prophylactic vaccines into clinical practice.
• Understanding the impact and cost-effectiveness of HPV prophylactic vaccines on public health
• Enhancing knowledge and updating scientific insights in the HPV risk management and testing
• Implementation of guidelines for cervical disease; screening and management of cervical abnormalities.
• Uses of HPV DNA and mRNA testing in clinical practice in a rational and cost-effective way.
• Review different tools and techniques available in the field of HPV infection diagnosis and adapt the most appropriate strategies for patients.
• Anticipate trends in biomarkers and genotyping for diagnosis and prevention.
• Compare worldwide experience in the field of screening and prevention of cervical disease, including developed and developing countries.
• Apply skills to enable the improvement, expansion, and use of scientific data for decision making
• Determine the public health role of physicians in HPV associated cancer control: prevention through training, early detection, treatment and quality of life.
• Identify existing strategies and explore innovative community interventions for HPV associated cancer screening outreach, future management and public education.
• Provide a learning environment for clinicians entering the field of cancer prevention and control where they can interact informally with all the leaders in this area.